The art of drug synthesis / edited by Douglas S. Johnson, Jie Jack Li.
Material type:
TextPublication details: Hoboken, N.J. : Wiley-Interscience, c2007.Description: xv, 276 p. : illISBN: - 9780471752158 (cloth);0471752150 (cloth)
- QV 744
| Item type | Current library | Home library | Call number | Status | Barcode | |
|---|---|---|---|---|---|---|
Books
|
Dow International Medical College | Dow International Medical College | QV 744 .A78 2007 (Browse shelf(Opens below)) | Available | 00002187 |
Browsing Dow International Medical College shelves Close shelf browser (Hides shelf browser)
| No cover image available |
|
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
| QV 740 .B75 2010 British national formulary. | QV 744 .A54 2009 pharmaceutical Inorganic chemistry / Ritu Aneja | QV 744 .A76 1996 Pharmaceutical experimental design and interpretation / | QV 744 .A78 2007 The art of drug synthesis / | QV 744 .C36 1982 A textbook of pharmaceutical analysis / | QV 744 .C36 1982 A textbook of pharmaceutical analysis / | QV 744 .C44 2008 Chemistry and molecular aspects of drug design and action / |
Includes bibliographical references and index.
The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer: exemestane (aromasin), anastrozole (arimidex), and letrozole (femara) / Jie Jack Li -- Quinolone antibiotics: levofloxacin (levaquin), moxifloxacin (avelox), gemifloxacin (factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals: itraconazole (sporanox), fluconazole (diflucan), voriconazole (vfend), and fosfluconazole (prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza: oseltamivir phosphate (tamiflu), and zanamivir (relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors /Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Pin??eiro-Nun??ez -- GABAA receptor agonists for insomnia: zolpidem (ambien), zaleplon (sonata), eszopiclone (estorra, lunesta), and indiplon / Peter R. Guzzo -- [alpha]2[delta] ligands: neurontin (gabapentin) and lyrica (pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder: amphetamine (adderall), methylphenidate (ritalin), and atomoxetine (stratterra) / David L. Gray.
There are no comments on this title.